According to China SXT Pharmaceuticals latest financial reports the cash on hand of SXTC is $17.37M, an increase of 11.88% to 2022. At the end of 2022 company had $15.52M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $17.37M | 11.88% |
2022 | $15.52M | 16.44% |
2021 | $13.33M | 82.97% |
2020 | $7.29M | -20.19% |
2019 | $9.13M | - |